参考文献/References:
[1] Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract, 2014, 103(2):137-149.
[2] 中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏疾病防治临床指南. 中华糖尿病杂志, 2019, 11(1):15-28.
[3] 李 琳, 李全民. 糖尿病肾病美国糖尿病协会指南更新要点及治疗进展, 中华糖尿病杂志, 2020, 12(6):424-428.
[4] KDOQI. Clinical Practice Guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis, 2007, 49(2 Suppl 2):S12-154.
[5] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) . 中华内分泌代谢杂志, 2021, 37(4):311-397.
[6] 糖尿病肾病多学科诊治与管理共识专家组.糖尿病肾病多学科诊治与管理专家共识. 中国临床医生杂志, 2020, 48(5):522-527.
[7] American Diabetes Association. MicrovascularComplications and Foot Care:Standards of Medical Carein Diabetes-2020. Diabetes Care, 2020, 43(Suppl1):S135-S151.
[8] Zhu HG, Jiang ZS, Gong PY, et al. Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials. Lipids Health Dis, 2018, 17(1):141.
[9] Zhang H, Tao X, Shi L, et al. Evaluation of body composition monitoring for assessment of nutritional status in hemodialysis patients. Ren Fail, 2019, 41(1):377-383.
[10] 徐缘钊, 祁爱蓉, 徐 彩, 等. 糖尿病肾脏疾病血液透析患者与非糖尿病肾脏疾病血液透析患者人体成分测定分析. 临床肾脏病杂志, 2019, 19(6):392-395.
[11] 毛 琳, 李 莉. 2型糖尿病患者血清维生素D水平及其影响因素. 中国医科大学学报, 2017, 46(1):68-71.
[12] Peng Y, Li LJ. Serum 25-hydroxyvitamin D level and diabetic nephropathy in patients with type 2 diabetes mellitus. Int Urol Nephrol, 2015, 47(6):983- 989.
[13] 杜 渊, 蒋宏伟, 李春庆, 等. 25羟维生素D与中国人群糖尿病肾病进展风险相关性的 Meta 分析 . 海南医学, 2021, 32(1):119-127.
[14] 宫恽恒, 陈素贞, 丁海明. 2型糖尿病患者血清25-羟基维生素D浓度变化及意义. 现代医药卫生, 2016, 32(11):1622-1623.
[15] Lu Q, Wan Z, Guo J, et al. Association between serum 25-hydroxyvitamin D concentrations and mortality among adults with prediabetes. J Clin Endocrinol Metab, 2021, 106(10):e4039-e4048.
[16] Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation,Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guidelin. J Clin Endocrinol
Metab, 2011, 96(7):1911–1930.
[17] Schleicher RL, Sternberg MR, Potischman N, et al.Supplemental Vitamin D Increased Serum Total 25-Hydroxyvitamin D in the US Adult Population During 2007–2014. J Nutr, 2021, 151(8):2446-2454.
[18] 姜明霞, 许 琦, 王 宇,等. 糖尿病肾病病人营养状况及其与血清胱抑素 C 水平的相关性分析 . 肠外与肠内营养, 2014, 21(5):282-284.
[19] 陈艺虹,吕桂兰. 不同营养评估工具在重症肾脏病中的应用价
值分析. 肠外与肠内营养, 2021, 28(4):242-246.
相似文献/References:
[1]张 敏,陈 璐,瞿美娣,等.2型糖尿病病人合并非酒精性脂肪性肝病的危险因素分析[J].肠外与肠内营养杂志,2019,(05):271.[doi:DOI : 10.16151/j.1007-810x.2019.05.004]
ZHANG Min,CHEN Lu,Q? Mei-di,et al.Analysis of the risk factors for NAFLD in patients with T2DM[J].PARENTERAL & ENTERAL NUTRITION,2019,(02):271.[doi:DOI : 10.16151/j.1007-810x.2019.05.004]
[2]刘金钢.减重手术术式选择及对机体代谢的调节[J].肠外与肠内营养杂志,2020,(01):1.[doi:10.16151/j.1007-810x.2020.01.001]
[3]杨 翔,陈 敏,万文辉,等.肠内营养混悬液(TPF-DM)对超高龄2 型糖尿病病人营养、糖脂代谢及免疫功能的影响[J].肠外与肠内营养杂志,2021,(03):144.[doi:10.16151/j.1007-810x.2021.03.004]
YANG Xiang,CHEN Min,WAN Wen-hui,et al.The effects of enteral nutritional suspension(TPF-DM) on nutrition,
glucose and lipid metabolism and immune function in super aged
patients with Type 2 diabetes mellitus[J].PARENTERAL & ENTERAL NUTRITION,2021,(02):144.[doi:10.16151/j.1007-810x.2021.03.004]